Company profile · Sponsor
Pyxis
Pyxis Oncology
- Pipeline
- 8
- Drugs
- 0
- Patents
- 3
Quick answer
Pyxis (PYXS) is a pharma company. headquartered in BOSTON, MA, USA. listed on NYSE. NovaPharmaNews links 8 pipeline programs, 0 drugs, and 3 patents to this profile..
Company facts
Pipeline (8)
Search pipeline →-
APX005M
Pyxis
Melanoma
1 trial -
PYX-201
Pyxis
Advanced Solid Tumors
1 trial -
Phase 1/2 Study of PYX-201 in Combination with Pembrolizumab in Advanced Solid Tumors
Pyxis
Advanced Solid Tumors
1 trial -
APX005M treatment for recurrent or refractory primary malignant CNS tumor patients
Pyxis
Glioblastoma Multiforme
1 trial -
PYX-106
Pyxis
Solid Tumor
1 trial -
PYX-201
Pyxis
Solid Tumor
1 trial -
Phase 1 Study of PYX-106 in Solid Tumors
Pyxis
Solid Tumors
1 trial -
Phase 1 Study of PYX-201 in Solid Tumors
Pyxis
Advanced solid tumors
1 trial
Patents (3)
Search patents →Frequently asked questions
What is Pyxis?
Pyxis (PYXS) is a pharma company. headquartered in BOSTON, MA, USA. listed on NYSE. NovaPharmaNews links 8 pipeline programs, 0 drugs, and 3 patents to this profile..
What pipeline programs does Pyxis sponsor?
We track 8 ClinicalTrials.gov-linked programs for Pyxis, including APX005M and 7 more. Open each program for phase, modality, NCT IDs, and indication details.
Where does Pyxis company data come from?
Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.